CN113248438A - Pyrazole compound and preparation method thereof - Google Patents
Pyrazole compound and preparation method thereof Download PDFInfo
- Publication number
- CN113248438A CN113248438A CN202110533936.0A CN202110533936A CN113248438A CN 113248438 A CN113248438 A CN 113248438A CN 202110533936 A CN202110533936 A CN 202110533936A CN 113248438 A CN113248438 A CN 113248438A
- Authority
- CN
- China
- Prior art keywords
- phenyl
- pyrazole
- bromomethyl
- yield
- chloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 Pyrazole compound Chemical class 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 10
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 5
- 125000001624 naphthyl group Chemical group 0.000 claims abstract description 5
- 239000003513 alkali Substances 0.000 claims abstract description 4
- 150000001875 compounds Chemical class 0.000 claims abstract description 3
- 238000006243 chemical reaction Methods 0.000 claims description 41
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 34
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 32
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 28
- MGSGAFULKBVKMA-UHFFFAOYSA-N 5-(bromomethyl)-1,3-diphenylpyrazole Chemical compound BrCC1=CC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 MGSGAFULKBVKMA-UHFFFAOYSA-N 0.000 claims description 18
- 239000000706 filtrate Substances 0.000 claims description 17
- 229910052757 nitrogen Inorganic materials 0.000 claims description 17
- 238000010898 silica gel chromatography Methods 0.000 claims description 17
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 14
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 9
- 150000007857 hydrazones Chemical class 0.000 claims description 7
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- 239000000010 aprotic solvent Substances 0.000 claims description 6
- 239000002585 base Substances 0.000 claims description 6
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 6
- 239000001632 sodium acetate Substances 0.000 claims description 6
- 235000017281 sodium acetate Nutrition 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 4
- VNCNFFPBJVWCNO-UHFFFAOYSA-N BrCC1=CC(C(C=C2)=CC=C2Br)=NN1C1=CC=CC=C1 Chemical compound BrCC1=CC(C(C=C2)=CC=C2Br)=NN1C1=CC=CC=C1 VNCNFFPBJVWCNO-UHFFFAOYSA-N 0.000 claims description 4
- MONLHVHUNKVHMW-UHFFFAOYSA-N BrCC1=CC(C2=CC=CO2)=NN1C1=CC=CC=C1 Chemical compound BrCC1=CC(C2=CC=CO2)=NN1C1=CC=CC=C1 MONLHVHUNKVHMW-UHFFFAOYSA-N 0.000 claims description 4
- PZTVQJONKFXEFN-UHFFFAOYSA-N BrCC1=CC(C2=NC=CC=C2)=NN1C1=CC=CC=C1 Chemical compound BrCC1=CC(C2=NC=CC=C2)=NN1C1=CC=CC=C1 PZTVQJONKFXEFN-UHFFFAOYSA-N 0.000 claims description 4
- LBCMMDWHICSMNG-UHFFFAOYSA-N CC(C=C1)=CC=C1C(C=C1CBr)=NN1C1=CC=CC=C1 Chemical compound CC(C=C1)=CC=C1C(C=C1CBr)=NN1C1=CC=CC=C1 LBCMMDWHICSMNG-UHFFFAOYSA-N 0.000 claims description 4
- FHTFXKHSAJFGSJ-UHFFFAOYSA-N COC(C=C1)=CC=C1C(C=C1CBr)=NN1C1=CC=CC=C1 Chemical compound COC(C=C1)=CC=C1C(C=C1CBr)=NN1C1=CC=CC=C1 FHTFXKHSAJFGSJ-UHFFFAOYSA-N 0.000 claims description 4
- AEQKTKYUCYASAS-UHFFFAOYSA-N COC1=CC=CC(C(C=C2CBr)=NN2C2=CC=CC=C2)=C1 Chemical compound COC1=CC=CC(C(C=C2CBr)=NN2C2=CC=CC=C2)=C1 AEQKTKYUCYASAS-UHFFFAOYSA-N 0.000 claims description 4
- CLEHXXZNVWRTSW-UHFFFAOYSA-N ClC(C=C1)=CC=C1C(C=C1CBr)=NN1C1=CC=CC=C1 Chemical compound ClC(C=C1)=CC=C1C(C=C1CBr)=NN1C1=CC=CC=C1 CLEHXXZNVWRTSW-UHFFFAOYSA-N 0.000 claims description 4
- PUHLAVUODXFHBE-UHFFFAOYSA-N ClC(C=CC=C1)=C1C(C=C1CBr)=NN1C1=CC=CC=C1 Chemical compound ClC(C=CC=C1)=C1C(C=C1CBr)=NN1C1=CC=CC=C1 PUHLAVUODXFHBE-UHFFFAOYSA-N 0.000 claims description 4
- NIBHJBJITYGPBD-UHFFFAOYSA-N ClC1=CC=CC(C(C=C2CBr)=NN2C2=CC=CC=C2)=C1 Chemical compound ClC1=CC=CC(C(C=C2CBr)=NN2C2=CC=CC=C2)=C1 NIBHJBJITYGPBD-UHFFFAOYSA-N 0.000 claims description 4
- VBFBOQYQVJAJRT-UHFFFAOYSA-N FC(C(C=C1)=CC=C1C(C=C1CBr)=NN1C1=CC=CC=C1)(F)F Chemical compound FC(C(C=C1)=CC=C1C(C=C1CBr)=NN1C1=CC=CC=C1)(F)F VBFBOQYQVJAJRT-UHFFFAOYSA-N 0.000 claims description 4
- GMIRYKLRKKDKGX-UHFFFAOYSA-N FC(C=C1)=CC=C1C(C=C1CBr)=NN1C1=CC=CC=C1 Chemical compound FC(C=C1)=CC=C1C(C=C1CBr)=NN1C1=CC=CC=C1 GMIRYKLRKKDKGX-UHFFFAOYSA-N 0.000 claims description 4
- TUMORAVXWOSCDC-UHFFFAOYSA-N N#CC(C=C1)=CC=C1C(C=C1CBr)=NN1C1=CC=CC=C1 Chemical compound N#CC(C=C1)=CC=C1C(C=C1CBr)=NN1C1=CC=CC=C1 TUMORAVXWOSCDC-UHFFFAOYSA-N 0.000 claims description 4
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 3
- FLQRLAYTECFRFO-UHFFFAOYSA-N 5-(bromomethyl)-1-(4-bromophenyl)-3-phenylpyrazole Chemical compound BrCC1=CC(C=2C=CC=CC=2)=NN1C1=CC=C(Br)C=C1 FLQRLAYTECFRFO-UHFFFAOYSA-N 0.000 claims description 3
- CFKFOIYDVIADJI-UHFFFAOYSA-N CC(C)(C)C(C=C1CBr)=NN1C1=CC=CC=C1 Chemical compound CC(C)(C)C(C=C1CBr)=NN1C1=CC=CC=C1 CFKFOIYDVIADJI-UHFFFAOYSA-N 0.000 claims description 3
- RBJXKEUDBSWGHV-UHFFFAOYSA-N CC(C=C1)=CC=C1N(C(CBr)=C1)N=C1C1=CC=CC=C1 Chemical compound CC(C=C1)=CC=C1N(C(CBr)=C1)N=C1C1=CC=CC=C1 RBJXKEUDBSWGHV-UHFFFAOYSA-N 0.000 claims description 3
- AADPNISVPUHFSI-UHFFFAOYSA-N COC(C=C1)=CC=C1N(C(CBr)=C1)N=C1C1=CC=CC=C1 Chemical compound COC(C=C1)=CC=C1N(C(CBr)=C1)N=C1C1=CC=CC=C1 AADPNISVPUHFSI-UHFFFAOYSA-N 0.000 claims description 3
- DDPLOKRZRNSAAP-UHFFFAOYSA-N COC(C=CC=C1)=C1C(C=C1CBr)=NN1C1=CC=CC=C1 Chemical compound COC(C=CC=C1)=C1C(C=C1CBr)=NN1C1=CC=CC=C1 DDPLOKRZRNSAAP-UHFFFAOYSA-N 0.000 claims description 3
- FBOQEECPFOCZFM-UHFFFAOYSA-N ClC(C=C1)=CC=C1N(C(CBr)=C1)N=C1C1=CC=CC=C1 Chemical compound ClC(C=C1)=CC=C1N(C(CBr)=C1)N=C1C1=CC=CC=C1 FBOQEECPFOCZFM-UHFFFAOYSA-N 0.000 claims description 3
- DAQHLONTGPSVJW-UHFFFAOYSA-N ClC(C=CC=C1)=C1N(C(CBr)=C1)N=C1C1=CC=CC=C1 Chemical compound ClC(C=CC=C1)=C1N(C(CBr)=C1)N=C1C1=CC=CC=C1 DAQHLONTGPSVJW-UHFFFAOYSA-N 0.000 claims description 3
- OZPTVYWGIOHRJJ-UHFFFAOYSA-N ClC1=CC=CC(N(C(CBr)=C2)N=C2C2=CC=CC=C2)=C1 Chemical compound ClC1=CC=CC(N(C(CBr)=C2)N=C2C2=CC=CC=C2)=C1 OZPTVYWGIOHRJJ-UHFFFAOYSA-N 0.000 claims description 3
- CESYNMKPBBNYEJ-UHFFFAOYSA-N FC(C(C=C1)=CC=C1N(C(CBr)=C1)N=C1C1=CC=CC=C1)(F)F Chemical compound FC(C(C=C1)=CC=C1N(C(CBr)=C1)N=C1C1=CC=CC=C1)(F)F CESYNMKPBBNYEJ-UHFFFAOYSA-N 0.000 claims description 3
- NWPVHYKTYWLFQI-UHFFFAOYSA-N FC(C=C1)=CC=C1N(C(CBr)=C1)N=C1C1=CC=CC=C1 Chemical compound FC(C=C1)=CC=C1N(C(CBr)=C1)N=C1C1=CC=CC=C1 NWPVHYKTYWLFQI-UHFFFAOYSA-N 0.000 claims description 3
- 235000011056 potassium acetate Nutrition 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 125000000524 functional group Chemical group 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 2
- 238000007363 ring formation reaction Methods 0.000 abstract description 2
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 96
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 45
- 239000007787 solid Substances 0.000 description 45
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 30
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 30
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 24
- 238000005160 1H NMR spectroscopy Methods 0.000 description 24
- 238000002844 melting Methods 0.000 description 24
- 230000008018 melting Effects 0.000 description 24
- DFAGRRDPHYTEPN-UHFFFAOYSA-N O=C(N(C1=CC=CC=C1)NC1=CC=CC=C1)Cl Chemical compound O=C(N(C1=CC=CC=C1)NC1=CC=CC=C1)Cl DFAGRRDPHYTEPN-UHFFFAOYSA-N 0.000 description 18
- 230000015572 biosynthetic process Effects 0.000 description 17
- 238000003786 synthesis reaction Methods 0.000 description 17
- UOCCVDMCNJYVIW-UHFFFAOYSA-N prop-2-yne-1-sulfonic acid Chemical compound OS(=O)(=O)CC#C UOCCVDMCNJYVIW-UHFFFAOYSA-N 0.000 description 16
- 239000003208 petroleum Substances 0.000 description 15
- 239000000843 powder Substances 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 14
- 238000001308 synthesis method Methods 0.000 description 6
- 150000003217 pyrazoles Chemical class 0.000 description 4
- DWAFRNHSGKPWKB-UHFFFAOYSA-N BrCC1=CC(C2=CC=CC3=CC=CC=C23)=NN1C1=CC=CC=C1 Chemical compound BrCC1=CC(C2=CC=CC3=CC=CC=C23)=NN1C1=CC=CC=C1 DWAFRNHSGKPWKB-UHFFFAOYSA-N 0.000 description 3
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 3
- 238000010189 synthetic method Methods 0.000 description 3
- ZOCSXAVNDGMNBV-UHFFFAOYSA-N 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound NC1=C(S(=O)C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl ZOCSXAVNDGMNBV-UHFFFAOYSA-N 0.000 description 2
- 102000010907 Cyclooxygenase 2 Human genes 0.000 description 2
- 108010037462 Cyclooxygenase 2 Proteins 0.000 description 2
- 239000005899 Fipronil Substances 0.000 description 2
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 150000001805 chlorine compounds Chemical group 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229940013764 fipronil Drugs 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 229910000510 noble metal Inorganic materials 0.000 description 2
- JZCPYUJPEARBJL-UHFFFAOYSA-N rimonabant Chemical compound CC=1C(C(=O)NN2CCCCC2)=NN(C=2C(=CC(Cl)=CC=2)Cl)C=1C1=CC=C(Cl)C=C1 JZCPYUJPEARBJL-UHFFFAOYSA-N 0.000 description 2
- 229960003015 rimonabant Drugs 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- MMZHVLPZLHGLCY-UKTHLTGXSA-N (e)-3-(3-bromophenyl)-2-(1-methylbenzimidazol-2-yl)prop-2-enenitrile Chemical compound N=1C2=CC=CC=C2N(C)C=1C(\C#N)=C\C1=CC=CC(Br)=C1 MMZHVLPZLHGLCY-UKTHLTGXSA-N 0.000 description 1
- XGQBTFOINCGEAU-UHFFFAOYSA-N 1-(2-bromoprop-2-enyl)-2-phenylbenzimidazole Chemical compound N=1C2=CC=CC=C2N(CC(=C)Br)C=1C1=CC=CC=C1 XGQBTFOINCGEAU-UHFFFAOYSA-N 0.000 description 1
- NOIXNOMHHWGUTG-UHFFFAOYSA-N 2-[[4-[4-pyridin-4-yl-1-(2,2,2-trifluoroethyl)pyrazol-3-yl]phenoxy]methyl]quinoline Chemical compound C=1C=C(OCC=2N=C3C=CC=CC3=CC=2)C=CC=1C1=NN(CC(F)(F)F)C=C1C1=CC=NC=C1 NOIXNOMHHWGUTG-UHFFFAOYSA-N 0.000 description 1
- 102000009132 CB1 Cannabinoid Receptor Human genes 0.000 description 1
- 108010073366 CB1 Cannabinoid Receptor Proteins 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 description 1
- 229960000590 celecoxib Drugs 0.000 description 1
- 150000002429 hydrazines Chemical class 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002469 receptor inverse agonist Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a pyrazole compound and a preparation method thereof, wherein the structural formula of the compound is as follows:the R is1Is variously substituted phenyl, naphthyl, alkyl or heterocyclic aryl, R2Are variously substituted phenyl groups. The preparation method comprises the following steps: at a certain temperature, under the action of corresponding alkali, [3+2 ]]The aromatic cyclization reaction of (2) to synthesize the pyrazole compound containing the modifiable functional group. The preparation method provided by the invention has the advantages of simple operation, easily obtained raw materials, good tolerance of reacted functional groups, simultaneously introduced multiple substituent groups, easy separation of products and the like.
Description
Technical Field
The invention belongs to a synthesis method of a compound, and particularly relates to a pyrazole compound and a preparation method thereof.
Background
Pyrazole and its derivatives are an important class of parent nucleus structures in many agricultural, material and pharmaceutical chemistries, for example, the most successful non-steroidal antidepressants celecoxib and teposalin are selective cyclooxygenase 2 (COX-2) inhibitors, which contain a pyrazole parent nucleus in their structure. Both the selective CB1 cannabinoid receptor inverse agonist Rimonabant (Rimonabant) for the treatment of obesity and the insecticidal drug Fipronil (Fipronil) also contain a pyrazole nucleus. The structural formula is as follows:
the existing synthetic methods for pyrazole compounds mainly comprise: 1) synthesized by reacting 1,3 unsaturated carbonyl compound or analog with hydrazine or substituted hydrazine; 2) synthesized by a (3+2) cyclization reaction of a hydrazone or an analog thereof with an alkyne.
In the process of realizing the invention, the inventor finds that the pyrazole compounds synthesized by the existing synthesis method are basically substituted pyrazole, and cannot be used as a good synthon, so that the application of the pyrazole compounds in drug synthesis is limited.
The synthesis method comprises the following steps:
in conclusion, the development of a novel, simple and efficient synthetic method and the synthesis of the pyrazole compound with a modifiable functional group have very important application values.
Disclosure of Invention
The invention aims to provide a pyrazole compound, which has a structural formula as follows:
the R is1Is variously substituted phenyl, naphthyl, alkyl or heterocyclic aryl, R2Are variously substituted phenyl groups.
The invention also provides a pyrazole compound which comprises any one of the following components:
5- (bromomethyl) -1, 3-diphenyl-1H-pyrazole (example 1)
5- (bromomethyl) -1-phenyl-3- (p-tolyl) -1H-pyrazole (example 2)
5- (bromomethyl) -3- (4-methoxyphenyl) -1-phenyl-1H-pyrazole (example 3)
5- (bromomethyl) -3- (3-methoxyphenyl) -1-phenyl-1H-pyrazole (example 4)
5- (bromomethyl) -3- (2-methoxyphenyl) -1-phenyl-1H-pyrazole (example 5)
5- (bromomethyl) -3- (4-fluorophenyl) -1-phenyl-1H-pyrazole (example 6)
5- (bromomethyl) -3- (4-chlorophenyl) -1-phenyl-1H-pyrazole (example 7)
5- (bromomethyl) -3- (3-chlorophenyl) -1-phenyl-1H-pyrazole (example 8)
5- (bromomethyl) -3- (2-chlorophenyl) -1-phenyl-1H-pyrazole (example 9)
5- (bromomethyl) -3- (4-bromophenyl) -1-phenyl-1H-pyrazole (example 10)
5- (bromomethyl) -1-phenyl-3- (4- (trifluoromethyl) phenyl) -1H-pyrazole (example 11)
4- (5- (bromomethyl) -1-phenyl-1H-pyrazol-3-yl) benzonitrile (example 12)
5- (bromomethyl) -3- (naphthalen-1-yl) -1-phenyl-1H-pyrazole (example 13)
2- (5- (bromomethyl) -1-phenyl-1H-pyrazol-3-yl) pyridine (example 14)
5- (bromomethyl) -3- (furan-2-yl) -1-phenyl-1H-pyrazole (example 15)
5- (bromomethyl) -3- (tert-butyl) -1-phenyl-1H-pyrazole (example 16)
5- (bromomethyl) -3-phenyl-1- (p-tolyl) -1H-pyrazole (example 17)
5- (bromomethyl) -1- (4-methoxyphenyl) -3-phenyl-1H-pyrazole (example 18)
5- (bromomethyl) -1- (4-fluorophenyl) -3-phenyl-1H-pyrazole (example 19)
5- (bromomethyl) -1- (4-chlorophenyl) -3-phenyl-1H-pyrazole (example 20)
5- (bromomethyl) -1- (3-chlorophenyl) -3-phenyl-1H-pyrazole (example 21)
5- (bromomethyl) -1- (2-chlorophenyl) -3-phenyl-1H-pyrazole (example 22)
5- (bromomethyl) -1- (4-bromophenyl) -3-phenyl-1H-pyrazole (example 23)
5- (bromomethyl) -3-phenyl-1- (4- (trifluoromethyl) phenyl) -1H-pyrazole (example 24)
Another object of the present invention is to provide a method for preparing the pyrazole compound, which comprises:
completely dissolving 1.0 equivalent of chlorinated hydrazone, 0.5 to 5.0 equivalents of prop-2-alkynyl sulfate and 2.0 to 3.0 equivalents of alkali in an aprotic solvent, and stirring for reaction under the protection of nitrogen;
wherein the structural formula of the chlorinated hydrazone is as follows:
the R is1Is variously substituted phenyl, naphthyl, alkyl or heterocyclic aryl, R2Is variously substituted phenyl;
the structural formula of the prop-2-alkynyl sulfur salt is as follows:
and (2) filtering the reaction system obtained in the step (1), drying and concentrating the filtrate to obtain a residue, and performing silica gel column chromatography on the residue to obtain the pyrazole compound.
Further, in the step (1), the reaction temperature is 0 ℃, 10 ℃, or 25 ℃, preferably 0 ℃.
Further, in the step (1), the reaction time is 12 to 36 hours.
Further, the aprotic solvent is one or more selected from acetonitrile, dichloromethane, chloroform, acetone and 1, 2-dichloroethane, and is mixed in any ratio.
Further, the aprotic solvent is preferably chloroform.
Further, the alkali is selected from one or more of sodium acetate, potassium carbonate, cesium carbonate, sodium hydroxide, potassium acetate and triethylamine which are mixed according to any ratio.
Further, the base is preferably potassium carbonate.
Further, the amount of the base used is preferably 2.0 equivalents of the chlorinated hydrazone.
The inventor obtains a pyrazole compound with multiple functional groups by dissolving a chloro hydrazone derivative and a propyl-2-alkynyl sulfur salt in chloroform and stirring for 12-36 hours at the temperature of 0 ℃. The synthesis method has the advantages of high yield, convenient post-treatment, no need of heavy/noble metal catalyst, mild reaction temperature and easily obtained reaction raw materials, and provides a simple, easy and efficient synthesis method for obtaining the polysubstituted pyrazole compound.
The synthesis method of the polysubstituted pyrazole compound provided by the invention has the following characteristics: 1. no heavy/noble metal catalyst is needed; 2. the reaction temperature is milder than that of the conventional synthetic method; 3. the substrate has wide applicability, and various substrate structures can bear the reaction conditions.
Detailed Description
The invention will now be further illustrated by the following examples.
Example 15- (bromomethyl) -1, 3-diphenyl-1H-pyrazole
N-Phenylphenylhydrazinecarbonyl chloride (1.0mmol,1.0 equiv.), prop-2-ynylsulfonate (2.0mmol,2.0 equiv.) and potassium carbonate (2.0mmol,2.0 equiv.) were dissolved in 10mL of chloroform and stirred at 0 ℃ for 24 hours under nitrogen. After the reaction was completed, the reaction system was filtered, the filtrate was evaporated and concentrated to give a residue, and the obtained residue was separated and purified by silica gel column chromatography (petroleum ether: ethyl acetate: 100:1) to give a white powder with a yield of 60%.
White solid, yield 65%. The melting point is 93.8-96.2 ℃.1H-NMR(400MHz,CDCl3):δ7.86(dd, J=7.2,1.6Hz,2H),7.67-7.63(m,2H),7,54(t,J=7.6Hz,2H)7.47(t,J=7.2Hz, 1H),7.42(t,J=7.2Hz,2H),7.34(t,J=7.2Hz,1H),6.85(s,1H),4.51(s,2H)。13C NMR(100MHz,CDCl3):δ152.2,140.3,139.3,132.8,129.6,128.9,128.8,128.4, 126.0,125.4,106.2,21.3;HRMS calcd for C16H13BrN2+H+:313.0335,found: 313.0335。
Example 1 comparison of yield under different solvent conditions
Example 1 comparison of yield under different base conditions
Example 1 comparison of yields at different reaction temperatures and times
Example 1 comparison of yield under different equivalents of potassium carbonate
Example 1 comparison of yields for different equivalents of prop-2-ynylsulfonate
Comparative example 1: 5- (bromomethyl) -1, 3-diphenyl-1H-pyrazoles
N-Phenylphenylhydrazinecarbonyl chloride (1.0mmol,1.0 equiv.), prop-2-ynylsulfonate (2.0mmol,2.0 equiv.) and sodium acetate (2.0mmol,2.0 equiv.) were dissolved in 10mL acetonitrile and stirred at 0 ℃ for 12 hours under nitrogen. After the reaction was completed, the reaction system was filtered, the filtrate was evaporated and concentrated to give a residue, and the obtained residue was separated and purified by silica gel column chromatography (petroleum ether: ethyl acetate: 100:1) to give a white powder in a yield of 27%.
Comparative example 2: 5- (bromomethyl) -1, 3-diphenyl-1H-pyrazoles
N-Phenylphenylhydrazinecarbonyl chloride (1.0mmol,1.0 equiv.), prop-2-ynylsulfonate (2.0mmol,2.0 equiv.) and sodium acetate (2.0mmol,2.0 equiv.) were dissolved in 10mL of dichloromethane and stirred at 0 ℃ for 12 hours under nitrogen. After the reaction was completed, the reaction system was filtered, the filtrate was evaporated and concentrated to give a residue, and the obtained residue was separated and purified by silica gel column chromatography (petroleum ether: ethyl acetate: 100:1) to give a white powder in a yield of 33%.
Comparative example 3: 5- (bromomethyl) -1, 3-diphenyl-1H-pyrazoles
N-Phenylphenylhydrazinecarbonyl chloride (1.0mmol,1.0 equiv.), prop-2-ynylsulfonate (2.0mmol,2.0 equiv.) and sodium acetate (2.0mmol,2.0 equiv.) were dissolved in 10mL of chloroform and stirred at 0 ℃ for 12 hours under nitrogen. After the reaction was completed, the reaction system was filtered, the filtrate was evaporated and concentrated to give a residue, and the obtained residue was separated and purified by silica gel column chromatography (petroleum ether: ethyl acetate: 100:1) to give a white powder with a yield of 41%.
Comparative example 4: 5- (bromomethyl) -1, 3-diphenyl-1H-pyrazoles
N-Phenylphenylhydrazinecarbonyl chloride (1.0mmol,1.0 equiv.), prop-2-ynylsulfonate (2.0mmol,2.0 equiv.) and sodium acetate (2.0mmol,2.0 equiv.) were dissolved in 10mL of 1, 2-dichloroethane, and stirred at 0 ℃ for 12 hours under nitrogen. After the reaction was completed, the reaction system was filtered, the filtrate was evaporated and concentrated to give a residue, and the obtained residue was separated and purified by silica gel column chromatography (petroleum ether: ethyl acetate: 100:1) to give a white powder with a yield of 37%.
Comparative example 6: 5- (bromomethyl) -1, 3-diphenyl-1H-pyrazoles
N-Phenylphenylhydrazinecarbonyl chloride (1.0mmol,1.0 equiv.), prop-2-ynylsulfonate (2.0mmol,2.0 equiv.) and potassium acetate (2.0mmol,2.0 equiv.) were dissolved in 10mL of chloroform and stirred at 0 ℃ for 12 hours under nitrogen. After the reaction was completed, the reaction system was filtered, the filtrate was evaporated and concentrated to give a residue, and the obtained residue was separated and purified by silica gel column chromatography (petroleum ether: ethyl acetate: 100:1) to give a white powder with a yield of 26%.
Comparative example 7: 5- (bromomethyl) -1, 3-diphenyl-1H-pyrazoles
N-Phenylphenylhydrazinecarbonyl chloride (1.0mmol,1.0 equiv.), prop-2-ynylsulfonate (2.0mmol,2.0 equiv.) and triethylamine (2.0mmol,2.0 equiv.) were dissolved in 10mL of chloroform and stirred at 0 ℃ for 12 hours under nitrogen. After the reaction was completed, the reaction system was filtered, the filtrate was evaporated and concentrated to give a residue, and the obtained residue was separated and purified by silica gel column chromatography (petroleum ether: ethyl acetate: 100:1) to give a white powder with a yield of 44%.
Comparative example 8: 5- (bromomethyl) -1, 3-diphenyl-1H-pyrazoles
N-Phenylphenylhydrazinecarbonyl chloride (1.0mmol,1.0 equiv.), prop-2-ynylsulfonate (2.0mmol,2.0 equiv.) and potassium carbonate (2.0mmol,2.0 equiv.) were dissolved in 10mL of chloroform and stirred at 0 ℃ for 12 hours under nitrogen. After the reaction was completed, the reaction system was filtered, the filtrate was evaporated and concentrated to give a residue, and the obtained residue was separated and purified by silica gel column chromatography (petroleum ether: ethyl acetate: 100:1) to give a white powder in a yield of 57%.
Comparative example 9: 5- (bromomethyl) -1, 3-diphenyl-1H-pyrazoles
N-Phenylphenylhydrazinecarbonyl chloride (1.0mmol,1.0 equiv.), prop-2-ynylsulfonate (2.0mmol,2.0 equiv.) and potassium carbonate (2.0mmol,2.0 equiv.) were dissolved in 10mL of chloroform and stirred at 0 ℃ for 24 hours under nitrogen. After the reaction was completed, the reaction system was filtered, the filtrate was evaporated and concentrated to give a residue, and the obtained residue was separated and purified by silica gel column chromatography (petroleum ether: ethyl acetate: 100:1) to give a white powder with a yield of 60%.
Comparative example 10: 5- (bromomethyl) -1, 3-diphenyl-1H-pyrazoles
N-Phenylphenylhydrazinecarbonyl chloride (1.0mmol,1.0 equiv.), prop-2-ynylsulfonate (2.0mmol,2.0 equiv.) and potassium carbonate (2.0mmol,2.0 equiv.) were dissolved in 10mL of chloroform and stirred at 10 ℃ for 24 hours under nitrogen. After the reaction was completed, the reaction system was filtered, the filtrate was evaporated and concentrated to give a residue, and the obtained residue was separated and purified by silica gel column chromatography (petroleum ether: ethyl acetate: 100:1) to give a white powder with a yield of 49%.
Comparative example 11: 5- (bromomethyl) -1, 3-diphenyl-1H-pyrazoles
N-Phenylphenylhydrazinecarbonyl chloride (1.0mmol,1.0 equiv.), prop-2-ynylsulfonate (2.0mmol,2.0 equiv.) and potassium carbonate (2.0mmol,2.0 equiv.) were dissolved in 10mL of chloroform and stirred at 25 ℃ for 24 hours under nitrogen. After the reaction was completed, the reaction system was filtered, the filtrate was evaporated and concentrated to give a residue, and the obtained residue was separated and purified by silica gel column chromatography (petroleum ether: ethyl acetate: 100:1) to give a white powder with a yield of 26%.
Comparative example 12: 5- (bromomethyl) -1, 3-diphenyl-1H-pyrazoles
N-Phenylphenylhydrazinecarbonyl chloride (1.0mmol,1.0 equiv.), prop-2-ynylsulfonate (2.0mmol,2.0 equiv.) and potassium carbonate (2.5mmol,2.5 equiv.) were dissolved in 10mL of chloroform and stirred at 0 ℃ for 24 hours under nitrogen. After the reaction was completed, the reaction system was filtered, the filtrate was evaporated and concentrated to give a residue, and the obtained residue was separated and purified by silica gel column chromatography (petroleum ether: ethyl acetate: 100:1) to give a white powder in a yield of 51%.
Comparative example 13: 5- (bromomethyl) -1, 3-diphenyl-1H-pyrazoles
N-Phenylphenylhydrazinecarbonyl chloride (1.0mmol,1.0 equiv.), prop-2-ynylsulfonate (2.0mmol,2.0 equiv.) and potassium carbonate (3.0mmol,3.0 equiv.) were dissolved in 10mL of chloroform and stirred at 0 ℃ for 24 hours under nitrogen. After the reaction was completed, the reaction system was filtered, the filtrate was evaporated and concentrated to give a residue, and the obtained residue was separated and purified by silica gel column chromatography (petroleum ether: ethyl acetate: 100:1) to give a white powder with a yield of 55%.
Comparative example 14: 5- (bromomethyl) -1, 3-diphenyl-1H-pyrazoles
N-Phenylphenylhydrazinecarbonyl chloride (1.0mmol,1.0 equiv.), prop-2-ynylsulfonate (0.5mmol,0.5 equiv.) and potassium carbonate (2.0mmol,2.0 equiv.) were dissolved in 10mL of chloroform and stirred at 0 ℃ for 24 hours under nitrogen. After the reaction was completed, the reaction system was filtered, the filtrate was evaporated and concentrated to give a residue, and the obtained residue was separated and purified by silica gel column chromatography (petroleum ether: ethyl acetate: 100:1) to give a white powder with a yield of 41%.
Comparative example 15: 5- (bromomethyl) -1, 3-diphenyl-1H-pyrazoles
N-Phenylphenylhydrazinecarbonyl chloride (1.0mmol,1.0 equiv.), prop-2-ynylsulfonate (5.0mmol,5.0 equiv.) and potassium carbonate (2.0mmol,2.0 equiv.) were dissolved in 10mL of chloroform and stirred at 0 ℃ for 24 hours under nitrogen. After the reaction was completed, the reaction system was filtered, the filtrate was evaporated and concentrated to give a residue, and the obtained residue was separated and purified by silica gel column chromatography (petroleum ether: ethyl acetate: 100:1) to give a white powder with a yield of 45%.
Example 25- (bromomethyl) -1-phenyl-3- (p-tolyl) -1H-pyrazole
The synthesis procedure is as in example 1 except that N-phenylbenzenecarbazoyl chloride is replaced by (Z) -4-methoxy-N' -phenylbenzenecarbazoyl chloride to give a white solid with a yield of 64%.
White solid, yield 64%. The melting point is 96.5-100.1 ℃.1H-NMR(400MHz,CDCl3):δ7.76 (d,J=8.0Hz,2H),7,65(t,J=6.8Hz,2H),7.54(t,J=7.6Hz,2H),7.46(t,J=7.2 Hz,1H),7.23(d,J=8.0Hz,2H),6.82(s,1H),4.50(s,2H);13C NMR(100MHz, CDCl3):δ152.3,140.2,139.3,138.2,130.0,129.6,129.5,128.7,125.9,125.4,106.0, 21.5,21.4;HRMS calcd for C17H15BrN2+H+:327.0491,found:327.0488。
Example 35- (bromomethyl) -3- (4-methoxyphenyl) -1-phenyl-1H-pyrazole
The synthesis procedure is as in example 1 except that N-phenylbenzenecarbazoyl chloride is replaced by (Z) -4-methoxy-N' -phenylbenzenecarbazoyl chloride to give a white solid with a yield of 62%.
White solid, yield 62%. The melting point is 107.8-109.3 ℃.1H-NMR(400MHz,CDCl3):δ 7.81-7.78(m,2H),7.66-7.62(m,2H),7,55-7.51(m,2H),7.47-7.43(m,1H),6.95(d, J=8.8Hz,2H),6.77(s,1H),4.50(s,2H),3.84(s,3H);13C NMR(100MHz, CDCl3):δ159.9,152.0,140.20,139.4,129.6,128.7,127.3,125.7,125.4,114.3, 105.7,55.5,21.4;HRMS calcd for C17H15BrN2O+H+:343.0441,found:343.0443。
Example 45- (bromomethyl) -3- (3-methoxyphenyl) -1-phenyl-1H-pyrazole
The synthesis procedure is as in example 1 except that N-phenylbenzenecarbazoyl chloride is replaced by (Z) -3-methoxy-N' -phenylbenzenecarbazoyl chloride to give a white solid with a yield of 65%.
White solid, yield 65%. The melting point is 101.2-104.5 ℃.1H NMR(400MHz,CDCl3)δ 7.67-7.63(m,2H),7.56-7.51(m,2H),7.49-7.46(m,1H),7.45-7.42(m,2H),7.33(t, J=8.0Hz,1H),6.91-6.87(m,1H),6.83(s,1H),4.50(s,2H),3.87(s,3H);13C NMR(100MHz,CDCl3):δ160.2,152.1,140.3,139.3,134.3,129.9,129.6,128.8, 125.5,118.6,114.5,111.0,106.4,55.6,21.3;HRMS calcd for C17H15BrN2O+H+: 343.0441,found:343.0444。
Example 55- (bromomethyl) -3- (2-methoxyphenyl) -1-phenyl-1H-pyrazole
The synthesis procedure is as in example 1 except that N-phenylbenzenecarbazoyl chloride is replaced by (Z) -2-methoxy-N' -phenylbenzenecarbazoyl chloride to give a white solid with a yield of 49%.
White solid, yield 49%. The melting point is 115.1-117.3 ℃.1H NMR(400MHz,CDCl3)δ 8.06(dd,J=7.6,1.6Hz,1H),7.68-7.65(m,2H),7,55-7.51(m,2H),7.47-7.43(m, 1H),7.35-7.30(m,1H),7.12(d,J=2.4Hz,1H),7.03(td,J=7.6,1.2Hz,1H),7.00 (d,J=8.0Hz,1H),4.59(s,2H),3.94(s,3H);13C NMR(100MHz,CDCl3):δ 157.1,149.1,139.4,139.2,129.5,129.4,128.9,128.6,125.4,121.7,121.1,111.4, 110.2,55.7,21.7;HRMS calcd for C17H15BrN2O+H+:343.0441,found:343.0443。
Example 65- (bromomethyl) -3- (4-fluorophenyl) -1-phenyl-1H-pyrazole
The synthesis procedure is as in example 1 except that N-phenylbenzenecarbazoyl chloride is replaced by (Z) -4-fluoro-N' -phenylbenzenecarbazoyl chloride to give a white solid with a yield of 61%.
White solidYield 61%. The melting point is 106.5-111.4 ℃.1H NMR(400MHz,CDCl3)δ 7.85-7.81(m,2H),7,63(t,J=7.2Hz,2H),7.56-7.52(m,2H),7.49-7.45(m,1H), 7.10(d,J=8.8Hz,2H),6.79(s,1H),4.50(s,2H);13C NMR(100MHz,CDCl3):δ 164.3,161.8.,151.3,140.5,139.2,129.7,129.1,128.9,127.7(d,J=21.5Hz),125.4, 115.9,115.7,105.9,21.2;HRMS calcd for C16H12BrFN2+H+:331.0241,found: 331.0238。
Example 75- (bromomethyl) -3- (4-chlorophenyl) -1-phenyl-1H-pyrazole
The synthesis procedure is as in example 1 except that N-phenylbenzenecarbazoyl chloride is replaced by (Z) -4-chloro-N' -phenylbenzenecarbazoyl chloride to give a white solid with a yield of 66%.
White solid, yield 66%. The melting point is 100.2-104.0 ℃.1H NMR(400MHz,CDCl3)δ 7.79(d,J=7.2Hz,2H),7,63(t,J=6.4Hz,2H),7.54(t,J=6.0Hz,2H),7.48(t,J=6.0Hz,1H),7.38(d,J=7.2Hz,2H),6.81(s,1H),4.49(s,2H);13C NMR(100 MHz,CDCl3):δ151.1,140.6,139.1,134.2,131.4,129.7,129.1,129.0,127.2,125.4, 106.1,21.1;HRMS calcd for C16H12BrClN2+H+:346.9945,found:346.9941。
Example 85- (bromomethyl) -3- (3-chlorophenyl) -1-phenyl-1H-pyrazole
The synthesis procedure is the same as in example 1 except that N-phenylbenzenecarbazoyl chloride is replaced by (Z) -3-chloro-N' -phenylbenzenecarbazoyl chloride to give a white solid with a yield of 72%.
White solid, yield 72%. The melting point is 105.5-109.1 ℃.1H NMR(400MHz,CDCl3)δ 7.87(s,1H),7.72(d,J=6.0Hz,1H),7,64(t,J=7.8Hz,2H),7.55(t,J=6.0Hz,2H), 7.49(t,J=6.0Hz,1H),7.35-7.27(m,2H),6.83(s,1H),4.49(s,2H);13C NMR (100MHz,CDCl3):δ150.9,140.6,139.1,134.9,134.7,130.2,129.7,129.0,128.44, 126.1,125.4,124.1,106.2,21.1;HRMS calcd for C16H12BrClN2+H+:346.9945, found:346.9944。
Example 95- (bromomethyl) -3- (2-chlorophenyl) -1-phenyl-1H-pyrazole
The synthesis procedure is as in example 1 except that N-phenylbenzenecarbazoyl chloride is replaced by (Z) -2-chloro-N' -phenylbenzenecarbazoyl chloride to give a white solid with a yield of 51%.
White solid, yield 51%. The melting point is 114.8-120.1 ℃.1H NMR(500MHz,CDCl3)δ 7.91(dd,J=7.6,2.4Hz,1H),7.68-7.64(m,2H),7,56-7.52(m,2H),7.49-7.45(m, 2H),7.33-7.27(m,2H),7.10(s,1H),4.53(s,2H);13C NMR(100MHz,CDCl3):δ 149.8,139.5,139.2,132.5,131.8,130.8,130.6,129.6,129.4,128.9,127.1,125.4, 110.1,21.3;HRMS calcd for C16H12BrClN2+H+:346.9945,found:346.9941。
Example 105- (bromomethyl) -3- (4-bromophenyl) -1-phenyl-1H-pyrazole
The synthesis procedure is as in example 1 except that N-phenylbenzenecarbazoyl chloride is replaced by (Z) -4-bromo-N' -phenylbenzenecarbazoyl chloride to give a white solid with a yield of 61%.
White solid, yield 61%. The melting point is 99.8-103.2 ℃.1H NMR(400MHz,CDCl3)δ7.73 (d,J=8.4Hz,2H),7,63(t,J=7.2Hz,2H),7.54(t,J=7.6Hz,4H),7.47(t,J=7.2 Hz,1H),6.82(s,1H),4.50(s,2H);13C NMR(100MHz,CDCl3):δ151.1,140.6, 139.1,132.0,131.9,129.7,129.0,127.5,125.4,122.3,106.0,21.1;HRMS calcd for C16H12Br2N2+H+:390.9440,found:390.9435。
Example 115- (bromomethyl) -1-phenyl-3- (4- (trifluoromethyl) phenyl) -1H-pyrazole
The synthesis procedure is as in example 1 except that N-phenyl phenylhydrazinecarbonyl chloride is replaced by (Z) -N' -phenyl-4- (trifluoromethyl) phenylhydrazinecarbonyl chloride to give a white solid in 67% yield.
White solid, yield 67%. The melting point is 111.2-115.7 ℃.1H NMR(400MHz,CDCl3)δ7.98(d,J=8.0Hz,2H),7,66(t,J=7.2Hz,4H),7.58-7.54(m,2H),7.51-7.47(m, 1H),6.89(s,1H),4.51(s,2H);13C NMR(100MHz,CDCl3):δ150.8,140.8.,139.1, 129.7,129.1,126.1,125.9(q,J=7.9Hz),125.5,106.4,21.0;HRMS calcd for C17H12BrF3N2+H+:381.0209,found:381.0207。
Example 124- (5- (bromomethyl) -1-phenyl-1H-pyrazol-3-yl) benzonitrile
The synthesis procedure is as in example 1 except that N-phenylbenzenecarbazoyl chloride is replaced by (Z) -4-cyano-N' -phenylbenzenecarbazoyl chloride to give a white solid with a yield of 65%.
White solid, yield 65%. The melting point is 134.5-138.0 ℃.1H NMR(400MHz,CDCl3)δ 7.95(d,J=7.6Hz,2H),7,69(d,J=8.0Hz,2H),7.63(t,J=7.2Hz,2H),7.56(t,J= 7.2Hz,2H),7.52-7.48(m,1H),6.89(s,1H),4.50(s,2H);13C NMR(100MHz, CDCl3):δ150.2,141.1,138.9,137.3,132.8,129.8,129.3,126.3,125.4,119.2,111.7, 106.6,20.8;HRMS calcd for C17H12BrN3+H+:338.0287,found:338.0288。
Example 135- (bromomethyl) -3- (naphthalen-1-yl) -1-phenyl-1H-pyrazole
The synthesis procedure is as in example 1 except that N-phenylbenzenecarbazoyl chloride is replaced by (Z) -N' -phenyl-1-naphthylcarboximoyl chloride to give a white solid with a yield of 41%.
White solid, yield 41%. The melting point is 95.8-98.3 ℃.1H NMR(400MHz,CDCl3)δ8.60 (dd,J=7.2,1.6Hz,1H),7,92-7.88(m,2H),7.78(dd,J=7.2,1.2Hz,1H),7.75-7.71 (m,2H),7.59-7.52(m,5H),7.50-7.46(m,1H),6.87(s,1H),4.59(s,2H);13C NMR (100MHz,CDCl3):δ152.1,139.6,139.3,134.2,131.5,130.9,129.6,128.9,128.8, 128.6,127.5,126.7,126.2,126.1,125.6,125.4,110.0,21.3;HRMS calcd for C20H15BrN2+H+:363.0491,found:363.0489。
Example 142- (5- (bromomethyl) -1-phenyl-1H-pyrazol-3-yl) pyridine
The synthesis procedure is as in example 1 except that N-phenyl phenylhydrazinecarboxylic acid chloride is replaced by (Z) -N' -phenyl methyl pyridine hydrazinecarboxylic acid chloride to give a white solid with a yield of 32%.
White solid, yield 32%. The melting point is 91.2-95.4 ℃.1H NMR(400MHz,CDCl3)δ8.64 (d,J=4.8Hz,1H),8.03(d,J=8.0Hz,1H),7.73(td,J=8.0,1.6Hz,1H),7.67-7.63 (m,2H),7.56-7.51(m,2H),7.49-7.46(m,1H),7.25-7.22(m,1H),7.19(s,1H),4.51 (s,2H);13C NMR(100MHz,CDCl3):δ152.4,151.8,149.6,140.7,139.2,136.9, 129.7,129.0,125.6,123.1,120.4,107.6,21.2;HRMS calcd for C15H12BrN3+H+: 314.0287,found:314.0288。
Example 155- (bromomethyl) -3- (furan-2-yl) -1-phenyl-1H-pyrazole
The synthesis procedure is as in example 1 except that N-phenylbenzenecarbazoyl chloride is replaced by (Z) -N' -phenylfuran-2-carbohydrazide oyl chloride to give a white solid with a yield of 40%.
White solid, yield 40% and melting point 72.6-76.8 ℃.1H NMR(400MHz,CDCl3)δ 7.63-7.60(m,2H),7.53(t,J=7.6Hz,2H),7.47-7.44(m,2H),6.77(s,1H),6.75(d,J =2.8Hz,1H),6.48-6.47(m,1H),4.47(s,2H);13C NMR(100MHz,CDCl3):δ 148.3,144.8,142.4,140.2,139.0,129.6,129.0,125.6,111.6,106.7,105.8,21.0; HRMS calcd for C14H11BrN2+H+:303.0128,found:303.0122。
Example 165- (bromomethyl) -3- (tert-butyl) -1-phenyl-1H-pyrazole
The synthesis procedure is as in example 1 except that N-phenyl phenylhydrazinecarbonyl chloride is replaced by (Z) -N' -phenyl pivaloyl chloride to give a white solid with a yield of 65%.
White solid, yield 65%. The melting point is 68.9-72.4 ℃.1H NMR(400MHz,CDCl3)δ7.57 (d,J=7.2Hz,2H),7.49(t,J=8.0Hz,2H),7.40(t,J=7.2Hz,1H),6.39(s,1H), 4.46(s,2H),1.35(s,9H);13C NMR(100MHz,CDCl3):δ162.8,139.6,138.9,129.5, 128.3,125.3,105.7,32.4,30.7,21.9;HRMS calcd for C14H17BrN2+H+:293.0648, found:293.0644。
Example 175- (bromomethyl) -3-phenyl-1- (p-tolyl) -1H-pyrazole
The procedure was as in example 1 except that N-phenylbenzenecarbazoyl chloride was replaced with (Z) -N' - (p-tolyl) phenylcarbazoyl chloride to give a white solid in 57% yield.
White solid, yield 57%. The melting point is 85.0-88.3 ℃.1H NMR(400MHz,CDCl3)δ7.86 (dd,J=7.2,1.6Hz,2H),7,53-7.49(m,2H),7.41(t,J=7.6Hz,2H),7.35-7.43(m, 3H),6.83(s,1H),4.49(s,2H);13C NMR(100MHz,CDCl3):δ152.0,140.3,138.9, 136.8,132.9,130.2,128.9,128.3,126.0,125.4,105.9,21.4,21.3;HRMS calcd for C17H15BrN2+H+:327.0491,found:327.0487。
Example 185- (bromomethyl) -1- (4-methoxyphenyl) -3-phenyl-1H-pyrazole
The procedure is as in example 1 except that N-phenylbenzenecarbazoyl chloride is replaced by (Z) -N' - (4-methoxyphenyl) phenylcarbazoyl chloride to give a white solid in 47% yield.
White solid, yield 47%. The melting point is 114.4-118.2 ℃.1H NMR(400MHz,CDCl3)δ 7.85(d,J=6.8Hz,2H),7,54(t,J=8.0Hz,2H),7.41(t,J=7.2Hz,2H),7.33(t,J= 6.8Hz,1H),7.03(d,J=8.4Hz,2H),6.81(s,1H),4.46(s,2H),3.88(s,3H);13C NMR(100MHz,CDCl3):δ160.0,151.9,140.4,133.0,132.2,128.9,128.3,127.1, 125.9,114.7,105.6,55.8,21.3;HRMS calcd for C17H15BrN2O+H+:343.0441, found:343.0443。
Example 195- (bromomethyl) -1- (4-fluorophenyl) -3-phenyl-1H-pyrazole
The procedure is as in example 1 except that N-phenylbenzenecarbazoyl chloride is replaced by (Z) -N' - (4-fluorophenyl) phenylcarbazoyl chloride to give a white solid in 75% yield.
White solid, yield 75%. The melting point is 101.7-104.3 ℃.1H NMR(400MHz,CDCl3)δ 7.84(dd,J=7.2,1.6Hz,2H),7,65-7.60(m,2H),7.42(t,J=7.2Hz,2H),7.34(t,J= 7.2Hz,1H),7.25-7.20(m,2H),6.83(s,1H),4.47(s,2H);13C NMR(100MHz, CDCl3):δ162.7(d,J=247Hz),152.3,140.5,135.4,132.7,128.9,128.5,127.5(d,J=9Hz),126.0,116.6(d,J=23Hz),106.1,21.1;HRMS calcd for C16H12BrFN2+H+: 331.0241,found:331.0244。
Example 205- (bromomethyl) -1- (4-chlorophenyl) -3-phenyl-1H-pyrazole
The procedure is as in example 1 except that N-phenylbenzenecarbazoyl chloride is replaced with (Z) -N' - (4-chlorophenyl) phenylcarbazoyl chloride to give a white solid in 63% yield.
White solid, yield 63%. The melting point is 88.6-93.4 ℃.1H NMR(400MHz,CDCl3)δ7.84 (d,J=7.2Hz,2H),7,61(t,J=8.0Hz,2H),7.51(d,J=8.4Hz,2H),7.42(t,J=7.2 Hz,2H),7.35(t,J=7.2Hz,1H),6.84(s,1H),4.49(s,2H);13C NMR(100MHz, CDCl3):δ152.5,140.4,137.8,134.6,132.6,129.8,128.9,128.6,126.6,126.0,106.5, 21.1;HRMS calcd for C16H12BrClN2+H+:346.9945,found:346.9941。
Example 215- (bromomethyl) -1- (3-chlorophenyl) -3-phenyl-1H-pyrazole
The procedure is as in example 1 except that N-phenylbenzenecarbazoyl chloride is replaced with (Z) -N' - (3-chlorophenyl) phenylcarbazoyl chloride to give a white solid in 78% yield.
White solid, yield 78%. The melting point is 77.2-79.5 ℃.1H NMR(400MHz,CDCl3)δ7.85 (d,J=6.0Hz,2H),7,71(s,1H),7.58(t,J=6.4Hz,1H),7.47-7.41(m,4H),7.38-7.33 (m,1H),6.85(s,1H),4.51(s,2H);13C NMR(100MHz,CDCl3):δ152.6,140.4, 140.3,135.4,132.6,130.6,129.0,128.9,128.6,126.0,125.7,123.2,106.7,21.0;HRMS calcd for C16H12BrClN2+H+:346.9945,found:346.9939。
Example 225- (bromomethyl) -1- (2-chlorophenyl) -3-phenyl-1H-pyrazole
The procedure is as in example 1 except that N-phenylbenzenecarbazoyl chloride is replaced by (Z) -N' - (2-chlorophenyl) phenylcarbazoyl chloride, the yield is 47%.
White solid, yield 47%. The melting point is 96.3-99.2 ℃.1H NMR(400MHz,CDCl3)δ7.85 (d,J=7.2Hz,2H),7,62(dd,J=7.2,1.6Hz,1H),7.58(dd,J=6.4,1.6Hz,1H), 7.51-7.46(m,2H),7.41(t,J=7.6Hz,2H),7.33(t,J=7.2Hz,1H),6.83(s,1H),4.36 (s,2H);13C NMR(100MHz,CDCl3):δ152.6,141.6,136.7,132.8,132.7,131.3, 130.7,130.5,128.9,128.5,128.0,126.1,105.1,20.5;HRMS calcd for C16H12BrClN2+H+:346.9945,found:346.9944。
Example 235- (bromomethyl) -1- (4-bromophenyl) -3-phenyl-1H-pyrazole
The procedure was as in example 1 except that N-phenylbenzenecarbazoyl chloride was replaced with (Z) -N' - (4-bromophenyl) phenylcarbazoyl chloride to give a white solid in 66% yield.
White solid, yield 66%. The melting point is 82.6-85.4 ℃.1H NMR(400MHz,CDCl3)δ7.84 (d,J=6.8Hz,2H),7,67(d,J=7.6Hz,2H),7.56(d,J=7.2Hz,2H),7.42(t,J=6.4 Hz,2H),7.37-7.32(m,1H),6.84(s,1H),4.49(s,2H);13C NMR(100MHz,CDCl3): δ152.6,140.4,138.3,132.8,132.6,129.0,128.6,126.8,126.0,122.6,106.6,21.1; HRMS calcd for C16H12Br2N2+H+:390.9440,found:390.9447。
Example 245- (bromomethyl) -3-phenyl-1- (4- (trifluoromethyl) phenyl) -1H-pyrazole
The procedure is as in example 1 except that N-phenylbenzenecarbazoyl chloride is replaced by (Z) -N' - (4- (trifluoromethyl) phenyl) phenylcarbazoyl chloride to give a white solid in 70% yield.
White solid, yield 70%. The melting point is 97.7-101.3 ℃.1H NMR(400MHz,CDCl3)δ 7.86-7.80(m,6H),7,43(t,J=7.2Hz,2H),7.36(t,J=7.2Hz,1H),6.88(s,1H),4.54 (s,2H);13C NMR(100MHz,CDCl3):δ153.0,142.2(d,J=1.6Hz),140.5,132.4, 129.0,128.7,126.9(q,J=3.6Hz),126.0,125.2,123.8(d,J=240.0Hz),107.2,21.0; HRMS calcd for C17H12BrF3N2+H+:381.0209,found:381.0204。
Other embodiments of the present application will be apparent to those skilled in the art from consideration of the specification and practice of the disclosure disclosed herein. This application is intended to cover any variations, uses, or adaptations of the invention following, in general, the principles of the application and including such departures from the present disclosure as come within known or customary practice within the art to which the invention pertains. It is intended that the specification and examples be considered as exemplary only, with a true scope and spirit of the application being indicated by the following claims.
It will be understood that the present application is not limited to the precise arrangements that have been described above and that various modifications and changes may be made without departing from the scope thereof. The scope of the application is limited only by the appended claims.
Claims (10)
2. The pyrazole compound according to claim 1, which is any one of the following compounds:
5- (bromomethyl) -1, 3-diphenyl-1H-pyrazole;
5- (bromomethyl) -1-phenyl-3- (p-tolyl) -1H-pyrazole;
5- (bromomethyl) -3- (4-methoxyphenyl) -1-phenyl-1H-pyrazole;
5- (bromomethyl) -3- (3-methoxyphenyl) -1-phenyl-1H-pyrazole;
5- (bromomethyl) -3- (2-methoxyphenyl) -1-phenyl-1H-pyrazole;
5- (bromomethyl) -3- (4-fluorophenyl) -1-phenyl-1H-pyrazole;
5- (bromomethyl) -3- (4-chlorophenyl) -1-phenyl-1H-pyrazole;
5- (bromomethyl) -3- (3-chlorophenyl) -1-phenyl-1H-pyrazole;
5- (bromomethyl) -3- (2-chlorophenyl) -1-phenyl-1H-pyrazole;
5- (bromomethyl) -3- (4-bromophenyl) -1-phenyl-1H-pyrazole;
5- (bromomethyl) -1-phenyl-3- (4- (trifluoromethyl) phenyl) -1H-pyrazole;
4- (5- (bromomethyl) -1-phenyl-1H-pyrazol-3-yl) benzonitrile;
2- (5- (bromomethyl) -1-phenyl-1H-pyrazol-3-yl) pyridine;
5- (bromomethyl) -3- (furan-2-yl) -1-phenyl-1H-pyrazole;
5- (bromomethyl) -3- (tert-butyl) -1-phenyl-1H-pyrazole;
5- (bromomethyl) -3-phenyl-1- (p-tolyl) -1H-pyrazole;
5- (bromomethyl) -1- (4-methoxyphenyl) -3-phenyl-1H-pyrazole;
5- (bromomethyl) -1- (4-fluorophenyl) -3-phenyl-1H-pyrazole;
5- (bromomethyl) -1- (4-chlorophenyl) -3-phenyl-1H-pyrazole;
5- (bromomethyl) -1- (3-chlorophenyl) -3-phenyl-1H-pyrazole;
5- (bromomethyl) -1- (2-chlorophenyl) -3-phenyl-1H-pyrazole;
5- (bromomethyl) -1- (4-bromophenyl) -3-phenyl-1H-pyrazole;
5- (bromomethyl) -3-phenyl-1- (4- (trifluoromethyl) phenyl) -1H-pyrazole.
3. A preparation method of a pyrazole compound is characterized by comprising the following steps:
completely dissolving 1.0 equivalent of chlorinated hydrazone, 0.5 to 5.0 equivalents of prop-2-alkynyl sulfate and 2.0 to 3.0 equivalents of alkali in an aprotic solvent, and stirring for reaction under the protection of nitrogen;
wherein the structural formula of the chlorinated hydrazone is as follows:
the R is1Is variously substituted phenyl, naphthyl, alkyl or heterocyclic aryl, R2Is variously substituted phenyl;
the structural formula of the prop-2-alkynyl sulfur salt is as follows:
and (2) filtering the reaction system obtained in the step (1), drying and concentrating the filtrate to obtain a residue, and performing silica gel column chromatography on the residue to obtain the pyrazole compound.
4. The method according to claim 3, wherein the reaction temperature in the step (1) is 0 ℃, 10 ℃, or 25 ℃, preferably 0 ℃.
5. The method according to claim 3, wherein the reaction time in the step (1) is 12 to 36 hours.
6. The method according to claim 3, wherein the aprotic solvent is one or more selected from acetonitrile, dichloromethane, chloroform, acetone, and 1, 2-dichloroethane, and is mixed in an arbitrary ratio.
7. The method according to claim 3, wherein the aprotic solvent is preferably chloroform.
8. The method according to claim 3, wherein the base is one or more selected from the group consisting of sodium acetate, potassium carbonate, cesium carbonate, sodium hydroxide, potassium acetate, and triethylamine, in any ratio.
9. The process of claim 3, wherein the base is potassium carbonate.
10. The method according to claim 3, wherein the base is used in an amount of 2.0 equivalents of the chlorinated hydrazone.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110533936.0A CN113248438B (en) | 2021-05-17 | 2021-05-17 | Pyrazole compound and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110533936.0A CN113248438B (en) | 2021-05-17 | 2021-05-17 | Pyrazole compound and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113248438A true CN113248438A (en) | 2021-08-13 |
CN113248438B CN113248438B (en) | 2022-04-12 |
Family
ID=77182231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110533936.0A Active CN113248438B (en) | 2021-05-17 | 2021-05-17 | Pyrazole compound and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113248438B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001072725A1 (en) * | 2000-03-24 | 2001-10-04 | Cor Therapeutics, Inc. | BICYCLIC SULFONYL AMINO INHIBITORS OF FACTOR Xa |
CN104961684A (en) * | 2015-07-21 | 2015-10-07 | 重庆大学 | Preparation method of 1,3,5-triaryl-4-trifluoromethyl-1-H pyrazol compounds |
CN105209447A (en) * | 2013-03-14 | 2015-12-30 | 百时美施贵宝公司 | Bicyclo [2.2.2] acid GPR120 modulators |
-
2021
- 2021-05-17 CN CN202110533936.0A patent/CN113248438B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001072725A1 (en) * | 2000-03-24 | 2001-10-04 | Cor Therapeutics, Inc. | BICYCLIC SULFONYL AMINO INHIBITORS OF FACTOR Xa |
CN105209447A (en) * | 2013-03-14 | 2015-12-30 | 百时美施贵宝公司 | Bicyclo [2.2.2] acid GPR120 modulators |
CN104961684A (en) * | 2015-07-21 | 2015-10-07 | 重庆大学 | Preparation method of 1,3,5-triaryl-4-trifluoromethyl-1-H pyrazol compounds |
Non-Patent Citations (3)
Title |
---|
MICHAEL TERNON ET AL.: "Synthesis of pyrazolidine, 1-pyrazoline, 2-pyrazoline derivatives by selenium-induced cyclization of homoallylhydrazines", 《TETRAHEDRON》 * |
TAO SHI ET AL.: "Sequential [3+2] annulation reaction of prop-2-ynylsulfonium salts and hydrazonyl chlorides: synthesis of pyrazoles containing functional motifs", 《CHEM. COMMUN.》 * |
来源于CIVENTICHEM提供的产品目录、CA等: ""STN检索报告1"", 《数据库REGISTRY(在线)》 * |
Also Published As
Publication number | Publication date |
---|---|
CN113248438B (en) | 2022-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4633462B2 (en) | Method for producing 3-halo-4,5-dihydro-1H-pyrazole | |
JPH0317071A (en) | Production of 3-amino-5-aminocarbonyl-1,2,4- triazoles derivatives | |
CN105777593A (en) | Preparation method of beta-arone substituted sulfone compounds | |
Yavari et al. | Tandem synthesis of highly functionalized pyrazole derivatives from terminal alkynes, sulfonyl azides, diethyl azadicarboxylate, and sodium arylsulfinates | |
AU2003253776A1 (en) | Cck-1 receptor modulators | |
SK694A3 (en) | Process for the preparation of diphenyl derivatives | |
JPH08319272A (en) | Production of 1-haloaryl heterocyclic compound for agricultural chemical | |
CN113248438B (en) | Pyrazole compound and preparation method thereof | |
CN110511189B (en) | 5-amino-1,2,4-oxadiazole derivative and synthetic method thereof | |
KR20070028510A (en) | alpha;,beta;-UNSATURATED ESTERS AND ACIDS BY STEREOSELECTIVE DEHYDRATION | |
KR20180112795A (en) | Method for producing carboxamide | |
JPH0124152B2 (en) | ||
JPS6377861A (en) | Manufacture of 4-substituted 1-aryl-5-amino- pyrazole | |
Seyrani et al. | A sequential Ugi–Smiles/transition-metal-free endo-dig Conia–ene cyclization: the selective synthesis of saccharin substituted 2, 5-dihydropyrroles | |
AU2004256106A1 (en) | CCK-1 receptor modulators | |
JPH01230562A (en) | Phenyltriazole derivative and insecticide | |
Pereira et al. | Synthesis of diverse N-acyl-pyrazoles via cyclocondensation of hydrazides with α-oxeketene dithioacetal | |
CN101193864B (en) | Pyrazole-1-carboxylic ester derivative, method for producing the same and method for producing pyrazole derivative | |
Verma et al. | Synthesis of new 2, 3-disubstituted pyridines containing a 1, 2, 3-triazole in the side-chain via one-pot copper-catalyzed azide-alkyne cycloaddition | |
KR102520302B1 (en) | Methyl 4-[(4,5-dihydro-3-methoxy-4-methyl-5-oxo-1H-1,2,4-triazol-1-yl)carbonyl)sulfamoyl]-5-methyl Method for preparing thiophene-3-carboxylate | |
KR102037758B1 (en) | 3-ALKYLATED IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AND ITS PREPARATION METHOD | |
EP0310061A1 (en) | 5-Mono or Disubstituted-3-(phenyl or 2-naphthalenyl)-3-[(1H-imidazol-1-ylmethyl) or (1H-1,2,4-triazol-1-ylmethyl)]-2-(methyl or benzyl)isoxazolidines | |
JP2004217542A (en) | Method for producing 4,5-dialkoxycarbonylimidazole | |
CN111057058A (en) | Method for preparing 1H- [1,2,3] -triazolo [4,5-c ] quinoline compound | |
JP2003523341A (en) | Process for producing (pyridinylidene) -phthalides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |